CCND2 and B-cell chronic lymphocytic leukemia: Due to the problem of obtaining complete medical information for all CLL patients enrolled in the genetic assay, we were only able to analyze the association between CDKN1B and CCND2 gene polymorphisms in relation to disease progression in 47 patients.